The Patent Finder

Terms ending in 2029

Allergan, Inc.

Every in-force patent on Allergan, Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 7,902,247SUBSTITUTED-ARYL-2-Phenylethyl-1H-IMIDAZOLE Compounds as Subtype Selective Modulators of Alpha 2B And/Or Alpha 2C Adrenergic Receptors
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 7,993,288Anatomical Recognition and Dimensional Analysis of Breast Volume to Assist Breast Surgery
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 8,648,853Anatomical Recognition, Orientation and Display of an Upper Torso to Assist Breast Surgery
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 9,129,055Anatomical Recognition, Orientation and Display of an Upper Torso to Assist Breast Surgery
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US D721,433Unit Dose Vials
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US D721,434Unit Dose Vial
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 8,722,097Polymeric Microparticles Made in an Oil-In Water Emulsion Comprising a Prostamide
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 8,524,494Low Oxygen Tension and BFGF Generates a Multipotent Stem Cell from a Fibroblast in Vitro
In force
 · Medium confidence
Allergan Sales, LLCIn forceMedium confidence
US 8,535,913Soluble composition for promoting hair growth produced by the hypoxic culture of fibroblast cells
In force
 · Low confidence
Allergan Sales, LLCIn forceLow confidence
US 10,538,736Conditioned Medium and Extracellular Matrix Compositions from Cells Cultured Under Hypoxic Conditions
In force
 · Medium confidence
Allergan Sales, LLCIn forceMedium confidence
74 more term ends in 2029 · Pro
10 of 84 patents shown. Soonest term end first, then patent number.
Pro members see all 84.
Upgrade to Pro
82 of these are in force and held by Allergan, Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited